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Background
An estimated 9 out of 10 individuals live where air quality 
exceeds World Health Organization guidelines.1 This is the 
result of high levels of ambient air pollution (AAP) which is 
made up of components from naturally occurring (ie, wildfires) 
or anthropogenic (ie, traffic-related air pollution, prescribed 
burns) sources. While airborne pollutants vary by source, season, 
and location, it is well established that particulate matter (PM) 
smaller than 2.5 µm in diameter (PM2.5) is of great importance 
to human health due to penetration of lung alveoli.2 The toxic 
potential of particles generated from different sources is likely 
to be unique and thus it is important to independently consider 
the health impacts and associated mechanisms of major sources. 
Wildfire smoke (WFS) is demonstrated to be a major source of 
AAP PM, contributing as much as 70% of PM2.5 in the western 
United States (US) on days when regulatory limits are exceeded.3 
Importantly, projections indicate that as early as the year 2100 
WFS could derive greater than 50% of total PM2.5 for the entire 
US.4 Alongside WFS, anthropogenic woodsmoke (AWS) has 
been estimated to contribute between 56 to 77% of PM2.5 in 
western communities in the winter.5 Geographical effects of 
total woodsmoke (TWS: comprised of WFS and AWS) air pol-
lution extend beyond immediate regions where biomass com-
bustion occurs due to the ability of smoke particulate to travel 
great distances.
The health burden associated with smoke exposure is of 
concern as increased wildfire prevalence is expected with 
warmer, drier environments concurrent with climate change. 
Unfortunately, common methods of wildfire prevention (eg, 
prescribed burning to reduce fuel sources) are themselves con-
tributors of AWS air pollution. With mitigation measures fac-
tored in, US deaths directly attributed to WFS are still expected 
to double as early as 2050.4 In addition to mortality, exposure 
to TWS has been correlated with morbidities such as cancer, 
cardiovascular disease, and respiratory syndromes. Recently, 
AWS exposure has also been associated with central nervous 
system (CNS) dysfunction, including Alzheimer’s disease 
(AD) dementia.6
AD is a progressive neurodegenerative disorder character-
ized by hallmark pathological markers such as senile amyloid-
beta (Aβ) plaques and neurofibrillary tau tangles (NFTs), as 
well as neuroinflammation, synaptic dysfunction, and neuronal 
cell death, which collectively results in marked cognitive 
impairment.7 AD accounts for 50% to75% of all known 
dementias.8 According to the Centers for Disease Control, AD 
is the 5th leading cause of death among the elderly, impacting 
nearly 5 million Americans over 65, a number which is expected 
to triple by 2060.9 Despite advances in our understanding of 
AD pathology, there remains no effective treatment or cure. 
Because of this, research efforts have transitioned from a treat-
ment approach to attempting preventative measures. While 
this push to better understand etiology has resulted in the 
characterization of a heritable subtype of AD, the majority of 
cases remain idiopathic in nature.10 Identifying modifiable risk 
factors and associated mechanisms could aid in the prevention 
of AD and help curb the rising tide of the disease.
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The molecular mechanisms that underlie the onset of mor-
bidity following TWS exposure are not well understood, espe-
cially as they differ from total AAP exposure. One promising 
theory is that combination of inflammation, oxidative stress, 
and epigenetic modifications might link airborne pollutant 
inhalation and subsequent disease pathogenesis. Several 
reviews have been conducted which explore the potential for 
environmental effect on epigenetic patterns to modify disease 
pathogenesis, including AD.11-17 Additionally, reviews have 
been conducted which explore the association between AAP 
exposure and onset of AD or dementia.18-23 Very recently, a 
review has assessed the effects of exposure to bushfire smoke 
on brain health.24 Taken together, these existing articles dem-
onstrate the growing body of literature which supports inter-
play between molecular mechanisms, including epigenetics, 
which underlie disease onset and occur following air pollution 
exposure. More work is needed to characterize the ability of 
TWS constituents, individually or as a whole, to influence epi-
genetics mechanisms that underlie AD though recent publica-
tions have suggested the plausibility of this relationship. 
Specifically, Wang et al.13 postulates that epigenetic modifica-
tions might help to explain the link between formaldehyde (a 
component of TWS) exposure and subsequent onset of AD.
Traditional approaches to address the nature of this rela-
tionship have been largely siloed with public health researchers 
reporting epidemiologic data, molecular biologists studying 
epigenetics and pathological progression, and chemists or envi-
ronmental scientists characterizing PM makeup and air pollu-
tion exposure events. However, recent cross-disciplinary efforts 
have allowed for the emergence of a new perspective. Our 
review seeks to explore existing literature and apply this novel 
lens to better understand how exposure to TWS and molecular 
mechanisms believed to be involved in AD onset are interre-
lated by referencing data from in vitro and in vivo models, as 
well as data from human epidemiologic analyses. While others 
have reviewed air pollution broadly, or traffic-related air pollu-
tion specifically, we here cite the expected increase in the con-
tribution of wood smoke to cumulative ambient air pollution as 
rationale which warrants evaluation of the status of the science 
and identification of major gaps in knowledge regarding links 
between TWS exposure and AD.
Total woodsmoke characterization
The most prevalent component of WFS by mass is PM2.5 
which is composed of: sulfate, nitrate, ammonium, chloride, 
elemental/organic carbon, and other air pollutants.25 These 
components are subject to variation based on geographic loca-
tion, season, and fuel source.3,26 Likewise, AWS contains highly 
variable levels of air pollutants depending upon the fuel source, 
conditions surrounding combustion,27,28 and the type of fire 
actively burning (ie, smolder, active flame).29 Some groups have 
described exposure assessment techniques that can be used to 
distinguish between the contribution of diesel emissions or 
woodsmoke to AAP30,31 As a result, reporting source appor-
tionment of PM2.5 is essential to accurately assess implications 
of exposure. Source apportionment studies provide strong evi-
dence for the consideration of TWS as a unique contributor to 
AAP.32 For example, data indicate that biomass combustion 
including TWS more strongly correlates with respiratory dis-
ease compared to motor vehicle sources,33 whereas motor vehi-
cle sources relative to AWS have been more strongly linked to 
cancer risk.34 Importantly, AAP exposure in studies that do not 
report source apportionment for PM2.5 may contain TWS pol-
lutants depending on the location and season. Because of this, 
some studies reporting AAP exposure data have been included 
in this review.
Woodsmoke exposure
Determining how TWS-derived particles come into contact 
with CNS tissue, or whether direct contact is necessary to 
induce AD-related outcomes, remains a challenge associated 
with this work (Figure 1). One potential for direct exposure is 
through uptake during inhalation. While no studies have dem-
onstrated this in models exposed to TWS PM, recent work has 
documented the ability of iron soot, a product of biomass com-
bustion, to enter the CNS directly via olfactory nerve bundles 
and subsequently travel to the brain.51 Another potential path-
way that has been proposed is that following TWS inhalation, 
PM passes through the lung-blood barrier and drives systemic 
inflammation, which leads to attenuation of the blood-brain 
barrier (BBB). While this has not been demonstrated in stud-
ies of WFS-derived PM, there are reports of altered BBB per-
meability following AAP exposure.58,59 Additionally, AWS has 
been demonstrated to activate the nuclear factor kappa B (NF-
kB) pathway as well as increase the release of tumor necrosis 
factor alpha (TNF-α) in mouse peritoneal macrophages.56 
This cascade leads to the systemic release of proinflammatory 
cytokines (IL-1β, 6, 12, 18) and is known to regulate BBB 
structural integrity.60 NF-kB mediated inflammation has also 
been reported in the lung, blood, and brain following AAP 
exposure in male wild-type (C57BL/6) mice.49 Collectively, 
this demonstrates the potential for induction of systemic 
inflammatory cascades, driven by inhalation exposure, to suffi-
ciently increase BBB permeability which could allow TWS 
particles to directly interact with neurons or microglia. While 
this is an attractive theory, additional work is required to char-
acterize the specific nature of TWS particle access to CNS tis-
sue, or if an alternate indirect mechanism negates the need for 
direct PM contact (ie, inflammatory mediators generated fol-
lowing inhalation of TWS particles travel to the brain and 
drive AD pathogenesis).
Woodsmoke and neurodegeneration
Notwithstanding full elucidation of TWS PM toxicokinetics 
related to CNS tissue, it is clear from the literature that both 
AAP and AWS exposures are associated with increased AD 
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onset.6,35-37 Attempts to characterize molecular explanations 
for AD onset have largely followed the thought that senile 
plaques and NFTs are driving factors in pathogenesis. 
Research published on this front has led to the development 
of the “amyloid hypothesis,” which was held as the general 
consensus surrounding AD onset for many years.61 Drug 
design studies targeting various components in amyloid 
hypothesis pathways have demonstrated little promise in 
clinical trials. As such, a shift favoring other theories regard-
ing disease origin has occurred.62 The emergence of an 
inflammation-centric view of AD has demonstrated signifi-
cant promise in recent years.63 Accordingly, we here assess 
TWS influence on AD in this context.
While no literature currently demonstrates a clear causative 
molecular mechanism to explain the correlation between either 
TWS or AAP exposure and AD onset, there are many indi-
vidual investigations that characterize inflammatory or cell 
stress pathway activation following an exposure event. These 
specific physiological changes are relevant to the pathogenesis 
of AD and are summarized in Table 1. Studies assessing occu-
pational health risks in firefighters have found that acute AWS 
exposure is associated with systemic inflammation.38,39 Similar 
observations have been made in mouse or cell models.49,50,55 Li 
et. al.55 speculate that the mechanism underlying cellular toxic-
ity following exposure-induced inflammation is linked to 
mitochondrial dysfunction as evidenced by reactive oxygen 
Figure 1. Working model demonstrating potential direct (1a and b) or indirect route (2) of CNS exposure to Total Woodsmoke (TWS) PM, inflammation-
mediated progression of AD, and contribution to hallmark pathology. (1a) PM2.5 enters the brain directly via the olfactory tract. (1b) PM2.5 enters the lung 
during inhalation and crosses the lung blood barrier, entering into systemic inflammation and allowing direct access to the BBB. (2) PM2.5 is inhaled, 
phagocytosed by innate immune cells, and induces systemic inflammation which can indirectly affect the BBB. Exposure event subsequently attenuates 
BBB integrity and CNS tissue becomes susceptible to exacerbation of AD pathology, neuroinflammation. While these pathways are discussed here as 
independent, the true exposure route may be a combination of these pathways.
Abbreviations: Aβ, amyloid beta; CNS, central nervous system; AD, Alzheimer’s disease; BBB, blood-brain barrier; PM, particulate matter.
Image created using BioRender.com.
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species (ROS) formation and oxidative stress. This is plausible 
given that ROS and NF-kB are known regulators of one 
another64 and have been implicated in AD risk.65 Alternatively, 
AAP exposed mouse cells display overexpression of cyclooxy-
genase-2 (COX-2) mediated by ROS formation following 
NF-kB activation. COX-2 is known to aggravate inflamma-
tion and plays a role in worsening AD pathology.66 Both of 
these molecular mechanisms represent a potential pathway for 
exposure-induced inflammation or cell stress cascades to result 
in cellular damage or cytotoxicity.
In addition to AD risk, chronic AAP exposure has been cor-
related with exacerbation of symptoms and increased incidence 
of hospitalization for those with dementia.40 Lee et al.41 found 
that, in patients with mild cognitive impairment (MCI) or AD, 
high levels of exposure to AAP PM2.5 worsens neuropsychiat-
ric symptoms. Furthermore, elderly females with elevated resi-
dential AAP PM2.5 exposure exhibit accelerated declines in 
executive functions, including immediate recall and new learn-
ing.42 Changes in cognition not only decrease the quality of life 
for the patient suffering from AD but also extend the impact 
of AD on society. Worsening neuropsychiatric state and decline 
in executive function increases caregiver burden67 and furthers 
the economic impact of AD.68 These implications strengthen 
the need for more extensive experimentation surrounding 
TWS exposure in the context of AD.
Complementing epidemiologic data suggesting a link 
between exposure to environmental air pollutants and altered 
AD phenotype, animal and cell models have been employed to 
investigate potential mechanistic links (Table 1). To date, these 
experiments are limited exclusively to the analysis of cumula-
tive AAP47,48,54 but future studies should investigate PM from 
unique sources, namely TWS or even individual PM generat-
ing events—prescribed burns, residential wood burning, wild-
fires. Two different transgenic AD mouse models69,70 have 
been used to explore AAP exposure effect on dementia onset or 
progression. In both cases, increased tissue pathological load 
and eventual clinical presentation worsened following inhala-
tion of the toxicant. These data demonstrate that exposure 
events have the potential to exacerbate the clinical progression 
of AD, independent of genetic predisposition to the disease.
In addition to identifying how TWS PM mechanistically 
influences CNS function, establishing windows of susceptibil-
ity, particularly during early life will be important for mitigat-
ing disease risk. Data suggests that human in utero exposure to 
AAP may significantly delay neurological development and 
impair cognitive function.43 Similarly, mouse pups exposed to 
AAP at timepoints representative of third trimester pregnancy 
in humans were found to display decrement in learning and 
memory.52 Both deficits in CNS structure and executive func-
tion are believed to have an association with the risk of AD 
onset or worsened disease phenotype.71 Accordingly, TWS-
induced CNS dysfunction could be partly explained by the 
developmental origins of health and disease (DOHaD) 
hypothesis72 which posits that early life exposure events can 
shape disease risk throughout the lifespan. There is a signifi-
cant lack of existing research to explore the cumulative effects 
of exposure throughout the life course. We have identified 4 
time points which seem to have distinct outcomes when 
assessed individually for exposure (Figure 2). Our understand-
ing regarding windows of susceptibility to TWS will hopefully 
be expanded in the coming years following efforts to prospec-
tively track health outcomes following major wildfire events 
such as the Camp Fire of 2018 which took place in California 
(eg, WHAT-Now-California study being led by researchers at 
UC Davis).
Some limited information from the animal literature sug-
gests that early life exposure to TWS may impact inflamma-
tory processes implicated in AD risk. Non-human primates 
exposed to WFS-derived PM in infancy presented with modu-
lation of immune response measured using peripheral blood 
mononuclear cells (PBMCs) during adolescence.53 This 
included a dampened response to toll-like receptor (TLR) 
stimulation and downstream signaling through NF-kB. 
Important in the context of AD, microglia expressing TLRs 
(TLR2, 4, and 9)73 are thought to help recognize and phagocy-
tose neurotoxic pathology (ie, Aβ plaques).74 Attenuation of 
innate immune response may occur in microglia as observed in 
PBMCs, and if so, there is potential for this to mediate TWS-
derived PM effect on AD etiology. Furthermore, it is known 
that PBMCs are recruited to the brain when microglia become 
overwhelmed in AD.75 If parenchymal Aβ load or TWS 
PM-induced neuroinflammation cause sufficient strain on 
microglia clearance ability, the recruitment of PBMCs that 
have been “damaged” by TWS exposure (as seen in the rhesus 
macaque following exposure) might significantly hinder the 
ability to clear parenchymal AD pathology and result in neu-
ronal death. This hypothesized mechanism of macrophage-
related AD disease risk has not been fully demonstrated and 
thus remains speculative.
Woodsmoke and epigenetics
Another appealing mechanism commonly evaluated as a con-
duit between exposure and disease is epigenetic alterations. 
Epigenetics can be defined as heritable features that affect gene 
expression, without altering the DNA sequence directly. The 
most well-characterized epigenetic modification is DNA 
methylation, which is the addition of a methyl group to a 5’ 
cytosine in a cytosine-guanine dinucleotide (CpG). DNA 
hypermethylation at CpG islands is typically associated with 
repression of gene transcription. Leading up to and shortly 
after birth, waves of DNA methylation patterns are established 
in a region or gene-specific fashion, and these patterns are 
inherently cell-specific.76 Unlike the genetic sequence, DNA 
methylation patterns are believed to remain plastic throughout 
the life span.77 Differential DNA methylation has been dem-
onstrated to be especially impactful at in utero or perinatal time 
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points,78 in support of the DOHaD hypothesis. Further work 
is necessary to implicate these timepoints in AD risk following 
TWS exposure, though early AAP exposure has been demon-
strated to affect neural developmental trajecotry.79 The dynamic 
nature of DNA methylation presents a way for environmental 
exposure to alter functional protein levels and affect system 
physiology. Recently, novel data has associated epigenetic mod-
ification with the onset of AD.80,81 Notably, global DNA hypo-
methylation—often linked to chromatin stability—has been 
implicated in AD onset.82 Review articles14,15 have explored 
potential reasons why CNS tissue is susceptible to DNA meth-
ylation changes citing reasons such as the large number of 
genes involved in the complex regulation of CNS development 
and maintenance relative to other tissues. Indeed, it has also 
been reported that in studies of AD discordance between 
monozygotic twins, differential DNA methylation profiles can 
be detected in PBMCs.83 While the directionality of this phe-
nomenon was not definitive in that study, this demonstrates 
novel evidence in support of further characterization of DNA 
methylation profiles in the context of AD risk. Notably, DNA 
methylation also serves as a potential target for therapeutic 
interventions84 and could ultimately help to mitigate disease 
risk.
Changes in DNA methylation following AAP and TWS 
exposure have been well demonstrated.44-46,57 While the dif-
ferential DNA methylation patterns reported here have not 
been demonstrated to have a definitive causative effect on AD, 
they are involved in the inflammatory pathways that are cur-
rently held as central mechanisms of disease onset and/or pro-
gression (Table 1). For instance, differential methylation of the 
gene coding for cAMP-regulated phosphoprotein 21 (ARPP21) 
was associated with acute AAP PM exposure.46 Aberrant 
expression of ARPP21 occurs with altered entorhinal cortical 
(EC) thickness which is known to correlate with worsened 
cognitive performance and exacerbation of AD progression.85 
In another study assessing epigenome-wide methylation of 
buffy coat DNA, AAP PM2.5 was associated with methylation 
of genes involved in immune cell maturation and function.44 
Additionally, differential CpG methylation in human periph-
eral blood samples has been related to immune system modula-
tion with respect to 24-h AAP PM2.5 levels.45 Innate immune 
system activation has been extensively studied as a potential 
link between peripheral inflammation and neuroinflammation 
in neurodegenerative disease73 and theories surrounding expo-
sure-induced aberrant innate immune response contribution to 
neurodegeneration have been addressed in this review.
Discussion
Here, we review the growing body of literature regarding the 
impact of air pollution on public health, and more specifically 
linking TWS exposure to AD onset. This focused evaluation is 
necessary and timely given the dramatic shift that is expected in 
air pollution source contribution from industrial/automobile to 
TWS. We have cited examples of plausible molecular mecha-
nisms whereby exposure-induced differential DNA methylation 
may alter AD risk, exacerbate other disease-relevant processes, 
and ultimately influence the phenotypic presentation.
Notably, comparing health outcomes from studies assessing 
effects of AAP, WFS, AWS, and traffic-related air pollution 
(TRAP) presents a major challenge because the composition of 
exposure constituents is inherently highly variable from sample 
to sample. Even comparing results from 2 studies that claim to 
measure the same source of pollution (eg, WFS) is problematic 
because of the complexity introduced by weather, geography, 
and fuel source. Also, many studies are conducted using esti-
mates of PM exposure gathered from sparsely located govern-
mental sites due to limitations in more localized data gathering 
methods which can include instrument availability or cost as 
well as participant recruitment. It is important to consider that 
there are inconsistencies in the way that estimated exposure 
models are generated86 and these methods may be particularly 
problematic in the rural west due to low sampler density. 
Additional consideration should also be given to the effect of 
TWS “ageing,” or the change in chemical composition as 
Figure 2. Representative time points of TWS exposure with potential for individual exposure events or cumulative effects to result in ultimate age-related 
phenotype.
Abbreviation: AD, Alzheimer’s disease.
Image created using BioRender.com.
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smoke spreads outward from the fire source.87 These factors 
highlight a need for better characterization of the toxicity of 
individual TWS components and mixtures under multiple 
environmental conditions. Our review also revealed inconsist-
encies in the way comorbidities and relevant disease status were 
recorded. Thus, when conducting future population health 
studies, researchers must consider health status and relevant 
AD risk factors in the population to improve interpretability 
and reproducibility of findings.
The implication that modifiable environmental exposures 
could drive disease onset or other aspects of pathogenesis raises 
the potential for interventions by which to ameliorate AD risk. 
At a population level, heightened awareness of the health 
threat posed by smoke exposure, coupled with increased efforts 
to reduce climate change and continued monitoring of air 
quality, would aid in the prevention of TWS generating events. 
At the individual level, some have posited that the impact of 
environmental toxicant exposure and subsequent development 
of dementia could be reversible.22 If DNA methylation is 
determined to be a mechanistic driver of pathogenesis, then the 
modification of disease-favoring states could reduce lifelong 
disease risk or heritability. Considering the link between TWS 
exposure and inflammation, a potential therapeutic might have 
broader applications to more neurodegenerative disorders in 
addition to AD.
Candidate gene methylation patterns represent potential 
disease biomarkers, especially if they could be detected in an 
accessible sample (eg, blood) before the progression of debili-
tating pathology. Mounting evidence exists to suggest that 
peripheral lymphocytes demonstrate AD-like inflammatory 
profiles before the onset of cognitive decline and independently 
of senile plaque or NFT pathology.88,89 In this way, exploration 
of differential DNA methylation patterns following exposure 
events in AD-relevant gene regions using peripheral samples 
(ie, buffy-coat DNA) may be useful as a minimally invasive 
diagnostic biomarker even if there is not found to be a causal 
involvement in neurodegenerative pathogenesis.
Model systems that complement epidemiological studies 
will be key to bolstering our understanding of the influence of 
woodsmoke on neuronal health. Future work using animal and 
cell models should investigate these molecular changes with 
varying study design endpoints to assess the efficacy of predic-
tion regarding the ultimate disease phenotype. The relative 
scale of aging for rodents coupled with the ease of genetic 
manipulation will allow more rapid exploration of different 
exposure durations and constituents, at varying time points, to 
generate data in support of a causal relationship.
Conclusion
The directionality and causality of the complex relationship 
between TWS exposure and the molecular underpinnings of 
neurodegenerative disease are not clear, yet predictions that 
TWS exposure will increase nationwide in the coming decades 
warrants further efforts to this end. The model proposed here 
demonstrates multiple ways that TWS exposure may influence 
AD onset and/or progression including through peripheral 
modulation of innate immune signaling, attenuation of the 
blood-brain barrier, and ultimately neuroinflammation leading 
to the parenchymal susceptibility to hallmark AD pathologies. 
Exposure timepoint, duration, and composition of TWS PM 
may distinctively influence the aforementioned pathways. 
TWS exposure events warrant further independent study from 
other AAP sources in the context of molecular mechanisms, 
specifically aberrant DNA methylation, underlying neuroin-
flammation, and AD.
AuThors’ ConTriBuTion
LM conceived the review topic and AS and LM contributed to the 
literature review as well as manuscript writing and editing.
referenCes
 1. Organization WH. Ambient Air Pollution. 2020. https://www.who.int/news-
room/fact-sheets/detail/ambient-(outdoor)-air-quality-and-health
 2. Lipsett M, Materna B. Wildfire smoke: a guide for public health officials. 
2008;1-27. https://www.airnow.gov/sites/default/files/2019-10/wildfire-smoke-
guide-revised-2019.pdf
 3. Liu JC, Mickley LJ, Sulprizio MP, et al. Particulate air pollution from wildfires 
in the Western US under climate change. Clim Change. 2016;138:655-666. 
doi:10.1007/s10584-016-1762-6.
 4. Ford B, Val Martin M, Zelasky SE, et al. Future fire impacts on smoke concen-
trations, visibility, and health in the contiguous United States. GeoHealth. 
2018;2:229-247. doi:10.1029/2018gh000144.
 5. Ward T, Lange T. The impact of wood smoke on ambient PM2.5 in northern 
Rocky Mountain valley communities. Environ Pollut. 2010;158:723-729. 
doi:10.1016/j.envpol.2009.10.016.
 6. Oudin A, Segersson D, Adolfsson R, Forsberg B. Association between air pollu-
tion from residential wood burning and dementia incidence in a longitudinal study 
in Northern Sweden. PLoS One. 2018;13:1-15. doi:10.1371/journal.pone.0198283.
 7. Alzheimer’s Association. 2020 Alzheimer’s disease facts and figures: special report. 
2020.
 8. Lane CA, Hardy J, Schott JM. Alzheimer’s disease. Eur J Neurol. 2018;25:59-70. 
doi:10.1111/ene.13439
 9. Matthews KA, Xu W, Gaglioti AH, Holt JB, Croft JB, Mcguire LC. Racial and 
ethnic estimates of Alzheimer’s disease and related dementias in the United 
States (2015–2060) in adults aged ⩾65 years. Alzheimers Dement. 2020;15:17-24. 
doi:10.1016/j.jalz.2018.06.3063.Racial.
 10. Alkadhi K, Eriksen J. The complex and multifactorial nature of Alzheimer’s dis-
ease. Curr Neuropharmacol. 2011;9:586. doi:10.2174/157015911798376235.
 11. Ho S-M, Johnson A, Tarapore P, Janakiram V, Zhang X, Leung Y-K. Environ-
mental epigenetics and its implication on disease risk and health outcomes. ILAR 
J. 2012;53:289-305. doi:10.1093/ilar.53.3-4.289.
 12. Barouki R, Melen E, Herceg Z, et al. Epigenetics as a mechanism linking devel-
opmental exposures to long-term toxicity. Environ Int. 2018;114:77-86. 
doi:10.1016/j.envint.2018.02.014.
 13. Wang F, Chen D, Wu P, Klein C, Jin C. Formaldehyde, epigenetics, and 
Alzheimer’s disease. Chem Res Toxicol. 2019;32:820-830. doi:10.1021/acs.
chemrestox.9b00090.
 14. Santos-Rebouças CB, Pimentel MMG. Implication of abnormal epigenetic pat-
terns for human diseases. Eur J Hum Genet. 2007;15:10-17. doi:10.1038/
sj.ejhg.5201727.
 15. Mattson MP. Methylation and acetylation in nervous system development and 
neurodegenerative disorders. Ageing Res Rev. 2003;2:329-342. doi:10.1016/
S1568-1637(03)00013-8.
 16. Ferrari L, Carugno M, Bollati V. Particulate matter exposure shapes DNA 
methylation through the lifespan. Clin Epigenetics. 2019;11:129. doi:10.1186/
s13148-019-0726-x.
 17. Shi Y, Zhao T, Yang X, et al. PM2.5-induced alteration of DNA methylation and 
RNA-transcription are associated with inflammatory response and lung injury. 
Sci Total Environ. 2019;650:908-921. doi:10.1016/j.scitotenv.2018.09.085.
 18. Kilian J, Kitazawa M. The emerging risk of exposure to air pollution on cognitive 
decline and Alzheimer’s disease – Evidence from epidemiological and animal 
studies. Biomed J. 2018;41:141-162. doi:10.1016/j.bj.2018.06.001.
Schuller and Montrose 9
 19. Peters R, Ee N, Peters J, Booth A, Mudway I, Anstey KJ. Air pollution and 
dementia: a systematic review. J Alzheimer’s Dis. 2019;70:S145-S163. doi:10.3233/
JAD-180631.
 20. Allen JL, Klocke C, Morris-Schaffer K, Conrad K, Sobolewski M, Cory-Slechta 
DA. Cognitive effects of air pollution exposures and potential mechanistic 
underpinnings. Curr Environ Heal reports. 2017;4:180-191. doi:10.1007/
s40572-017-0134-3.
 21. de Prado Bert P, Mercader EMH, Pujol J, Sunyer J, Mortamais M. The effects of 
air pollution on the brain: a review of studies interfacing environmental epidemi-
ology and neuroimaging. Curr Environ Heal reports. 2018;5:351-364. doi:10.1007/
s40572-018-0209-9.
 22. Genuis SJ, Kelln KL. Toxicant exposure and bioaccumulation: a common and 
potentially reversible cause of cognitive dysfunction and dementia. Behav Neurol. 
2015;2015:1-10. doi:10.1155/2015/620143.
 23. Calderón-Garcidueñas L, Leray E, Heydarpour P, Torres-Jardón R, Reis J. Air 
pollution, a rising environmental risk factor for cognition, neuroinflammation 
and neurodegeneration: the clinical impact on children and beyond. Rev Neurol 
(Paris). 2016;172:69-80. doi:10.1016/j.neurol.2015.10.008.
 24. Milton LA, White AR. The potential impact of bushfire smoke on brain health. 
Neurochem Int. 2020;139:104796. doi:10.1016/j.neuint.2020.104796.
 25. Harrison RM, Yin J. Particulate matter in the atmosphere: which particle prop-
erties are important for its effects on health? Sci Total Environ. 2000;249:85-101. 
doi:10.1016/S0048-9697(99)00513-6.
 26. Liu JC, Peng RD. The impact of wildfire smoke on compositions of fine particu-
late matter by ecoregion in the Western US. J Expo Sci Environ Epidemiol. 
2019;29:765-776. doi:10.1038/s41370-018-0064-7.
 27. Kocbach Bølling A, Pagels J, Yttri KE, et al. Health effects of residential wood 
smoke particles: the importance of combustion conditions and physicochemical 
particle properties. Part Fibre Toxicol. 2009;6:29. doi:10.1186/1743-8977-6-29.
 28. Agency USEP. Best wood-burning practices. 2020. https://19january2017 
snapshot.epa.gov/burnwise/burn-wise-best-burn-practices_.html
 29. Robinson MS, Chavez J, Velazquez S, Jayanty RKM. Chemical speciation of 
PM2.5 collected during prescribed fires of the coconino national forest near flag-
staff, arizona. J Air Waste Manag Assoc. 2004;54:1112-1123. doi:10.1080/104732
89.2004.10470985.
 30. Wallen A, Liden G, Hansson HC. Measured elemental carbon by thermo-
optical transmittance analysis in water-soluble extracts from diesel exhaust, 
woodsmoke, and ambient particulate samples. J Occup Environ Hyg. 2010;7:35-
45. doi:10.1080/15459620903368859.
 31. Braun A, Huggins FE, Kubátová A, et al. Toward distinguishing woodsmoke 
and diesel exhaust in ambient particulate matter. Environ Sci Technol. 
2008;42:374-380. doi:10.1021/es071260k.
 32. Díaz-Robles L, Díaz-Robles L, Cortés S, Carlos Ortega J, Vergara-Fernández 
A. Short term health effects of particulate matter: a comparison between wood 
smoke and multi-source polluted urban areas in chile. Aerosol Air Qual Res. 
2015;15:306-318. doi:10.4209/aaqr.2013.10.0316.
 33. Krall JR, Mulholland JA, Russell AG, et al. Associations between source-
specific fine particulate matter and emergency department visits for respira-
tory disease in four U.S. cities. Environ Health Perspect. 2017;125:97-103. 
doi:10.1289/EHP271.
 34. Cupitt LT, Glen WG, Lewtas J. Exposure and risk from ambient particle-bound 
pollution in an airshed dominated by residential wood combustion and mobile 
sources. Environ Health Perspect. 1994;102(suppl 4):75-84. doi:10.1289/
ehp.94102s475.
 35. Wu YC, Lin YC, Yu HL, et al. Association between air pollutants and dementia 
risk in the elderly. Alzheimer’s Dement Diagnosis, Assess Dis Monit. 2015;1:220-
228. doi:10.1016/j.dadm.2014.11.015.
 36. Li R-L, Ho Y-C, Luo C-W, Lee S-S, Kuan Y-H. Influence of PM2.5 exposure 
level on the association between Alzheimer’s Disease and allergic rhinitis: a 
National Population-Based Cohort Study. Int J Environ Res Public Health. 
2019;16:3357. doi:10.3390/ijerph16183357
 37. Chang KH, Chang MY, Muo CH, Wu TN, Chen CY, Kao CH. Increased risk 
of dementia in patients exposed to nitrogen dioxide and carbon monoxide: a pop-
ulation-based retrospective cohort study. PLoS One. 2014;9:e103078. 
doi:10.1371/journal.pone.0103078.
 38. Hejl AM, Adetona O, Diaz-Sanchez D, et al. Inflammatory effects of 
woodsmoke exposure among wildland firefighters working at prescribed burns at 
the savannah river site, SC. J Occup Environ Hyg. 2013;10:173-180. doi:10.1080/
15459624.2012.760064.
 39. Unosson J, Blomberg A, Sandström T, et al. Exposure to wood smoke increases 
arterial stiffness and decreases heart rate variability in humans. Part Fibre Toxi-
col. 2013;10:1-8. doi:10.1186/1743-8977-10-20.
 40. Cerza F, Renzi M, Gariazzo C, et al. Long-term exposure to air pollution and 
hospitalization for dementia in the Rome longitudinal study. Environ Health. 
2019;18:72. doi:10.1186/s12940-019-0511-5.
 41. Lee H, Kang JM, Myung W, et al. Exposure to ambient fine particles and neu-
ropsychiatric symptoms in cognitive disorder: a repeated measure analysis from 
the CREDOS (Clinical Research Center for Dementia of South Korea) study. 
Sci Total Environ. 2019;668:411-418. doi:10.1016/j.scitotenv.2019.02.447.
 42. Younan D, Petkus AJ, Widaman KF, et al. Particulate matter and episodic mem-
ory decline mediated by early neuroanatomic biomarkers of Alzheimer’s disease. 
Brain. 2020;143:289-302. doi:10.1093/brain/awz348.
 43. Guxens M, Lubczynska MJ, Muetzel RL, et al. Air pollution exposure during 
fetal life, brain morphology, and cognitive function in school-age children. Biol 
Psychiatry. 2018;84:295-303. doi:10.1016/j.biopsych.2018.01.016.
 44. Dai L, Mehta A, Mordukhovich I, et al. Differential DNA methylation and 
PM2.5 species in a 450K epigenome-wide association study. Epigenetics. 
2017;12:139-148. doi:10.1080/15592294.2016.1271853.
 45. Mostafavi N, Vermeulen R, Ghantous A, et al. Acute changes in DNA methyla-
tion in relation to 24h personal air pollution exposure measurements: a panel 
study in four European countries. Environ Int. 2018;120:11-21. doi:10.1016/j.
envint.2018.07.026.
 46. Gondalia R, Baldassari A, Holliday KM, et al. Methylome-wide association 
study provides evidence of particulate matter air pollution-associated DNA 
methylation. Environ Int. 2019;132:104723. doi:10.1016/j.envint.2019.03.071.
 47. Jew K, Herr D, Wong C, et al. Selective memory and behavioral alterations after 
ambient ultrafine particulate matter exposure in aged 3xTgAD Alzheimer’s dis-
ease mice. Part Fibre Toxicol. 2019;16:45. doi:10.1186/s12989-019-0323-3.
 48. Cacciottolo M, Wang X, Driscoll I, et al. Particulate air pollutants, APOE 
alleles and their contributions to cognitive impairment in older women and to 
amyloidogenesis in experimental models. Transl Psychiatry. 2017;7:e1022. 
doi:10.1038/tp.2016.280.
 49. Ku T, Li B, Gao R, et al. NF-kappaB-regulated microRNA-574-5p underlies 
synaptic and cognitive impairment in response to atmospheric PM2.5 aspiration. 
Part Fibre Toxicol. 2017;14:34. doi:10.1186/s12989-017-0215-3.
 50. Pardo M, Li C, He Q , et al. Mechanisms of lung toxicity induced by biomass 
burning aerosols. Part Fibre Toxicol. 2020;17:1-15. doi:10.1186/s12989- 
020-0337-x.
 51. Hopkins LE, Laing EA, Peake JL, et al. Repeated iron-soot exposure and nose-
to-brain transport of inhaled ultrafine particles. Toxicol Pathol. 2018;46:75-84. 
doi:10.1177/0192623317729222.
 52. Cory-Slechta DA, Allen JL, Conrad K, Marvin E, Sobolewski M. Developmen-
tal exposure to low level ambient ultrafine particle air pollution and cognitive 
dysfunction. Neurotoxicology. 2018;69:217-231. doi:10.1016/j.neuro.2017.12.003.
 53. Black C, Gerriets JE, Fontaine JH, et al. Early life wildfire smoke exposure is 
associated with immune dysregulation and lung function decrements in adoles-
cence. Am J Respir Cell Mol Biol. 2017;56:657-666. doi:10.1165/rcmb.2016- 
0380OC.
 54. Jang S, Kim EW, Zhang Y, et al. Particulate matter increases beta-amyloid and 
activated glial cells in hippocampal tissues of transgenic Alzheimer’s mouse: 
involvement of PARP-1. Biochem Biophys Res Commun. 2018;500:333-338. 
doi:10.1016/j.bbrc.2018.04.068.
 55. Li B, Guo L, Ku T, Chen M, Li G, Sang N. PM2.5 exposure stimulates COX-
2-mediated excitatory synaptic transmission via ROS-NF-KB pathway. Chemo-
sphere. 2018;190:124-134. doi:10.1016/j.chemosphere.2017.09.098.
 56. Leonard SS, Wang S, Shi X, Jordan BS, Castranova V, Dubick MA. Wood 
smoke particles generate free radicals and cause lipid peroxidation, DNA dam-
age, NFκB activation and TNF-α release in macrophages. Toxicology. 
2000;150:147-157. doi:10.1016/S0300-483X(00)00256-0.
 57. Hesselbach K, Kim G-J, Flemming S, et al. Disease relevant modifications of the 
methylome and transcriptome by particulate matter (PM2.5) from biomass com-
bustion. Epigenetics. 2017;12:779-792. doi:10.1080/15592294.2017.1356555.
 58. Liu F, Huang Y, Zhang F, et al. Macrophages treated with particulate matter 
PM2.5 induce selective neurotoxicity through glutaminase-mediated glutamate 
generation. J Neurochem. 2015;134:315-326. doi:10.1111/jnc.13135.
 59. Hajipour S, Farbood Y, Gharib-Naseri MK, et al. Exposure to ambient dusty 
particulate matter impairs spatial memory and hippocampal LTP by increasing 
brain inflammation and oxidative stress in rats. Life Sci. 2020;242:117210. 
doi:10.1016/j.lfs.2019.117210.
 60. Wenzel J, Schwaninger M. The blood–brain barrier and its regulation by NF-κB. 
e-Neuroforum. 2016;7:23-30. doi:10.1007/s13295-016-0022-6.
 61. Selkoe DJ, Hardy J. The amyloid hypothesis of Alzheimer’s disease at 25 years. 
EMBO Mol Med. 2016;8:595-608. doi:10.15252/emmm.201606210.
 62. Kametani F, Hasegawa M. Reconsideration of amyloid hypothesis and tau 
hypothesis in Alzheimer’s disease. Front Neurosci. 2018;12:25. doi:10.3389/
fnins.2018.00025.
 63. Kinney JW, Bemiller SM, Murtishaw AS, Leisgang AM, Salazar AM, Lamb 
BT. Inflammation as a central mechanism in Alzheimer’s disease. Alzheimer’s 
Dement Transl Res Clin Interv. 2018;4:575-590. doi:10.1016/j.trci.2018.06.014.
 64. Morgan MJ, Liu ZG. Crosstalk of reactive oxygen species and NF-κB signaling. 
Cell Res. 2011;21:103-115. doi:10.1038/cr.2010.178.
 65. Jones SV, Kounatidis I. Nuclear factor-kappa B and Alzheimer disease, unifying 
genetic and environmental risk factors from cell to humans. Front Immunol. 
2017;8:1805. doi:10.3389/fimmu.2017.01805.
 66. Wang P, Guan PP, Wang T, Yu X, Guo JJ, Wang ZY. Aggravation of Alzheim-
er’s disease due to the COX-2-mediated reciprocal regulation of IL-1β and Aβ 
10 Epigenetics Insights 
between glial and neuron cells. Aging Cell. 2014;13:605-615. doi:10.1111/
acel.12209.
 67. Koca E, Taşkapilioğlu Ö, Bakar M. Caregiver burden in different stages of 
Alzheimer’s disease. Noropsikiyatri Ars. 2017;54:82-86. doi:10.5152/npa.2017. 
11304.
 68. Xu J, Zhang Y, Qiu C, Cheng F. Global and regional economic costs of dementia: 
a systematic review. Lancet. 2017;390:S47. doi:10.1016/s0140-6736(17)33185-9.
 69. Oddo S, Caccamo A, Shepherd JD, et al. Triple-transgenic model of Alzheimer’s 
disease with plaques and tangles: Intracellular Aβ and synaptic dysfunction. 
Neuron. 2003;39:409-421. doi:10.1016/S0896-6273(03)00434-3.
 70. Youmans KL, Tai LM, Nwabuisi-Heath E, et al. APOE4-specific changes in 
Aβ accumulation in a new transgenic mouse model of alzheimer disease. J Biol 
Chem. 2012;287:41774-41786. doi:10.1074/jbc.M112.407957.
 71. Seifan A, Schelke M, Obeng-Aduasare Y, Isaacson R. Early life epidemiology of 
Alzheimer’s disease–A critical review. Neuroepidemiology. 2015;45:237-254. 
doi:10.1159/000439568.
 72. Barker DJP. The origins of the developmental origins theory. J Intern Med. 
2007;261:412-417. doi:10.1111/j.1365-2796.2007.01809.x.
 73. Wang M-M, Miao D, Cao X-P, Tan L, Tan L. Innate immune activation in 
Alzheimer’s disease. Ann Transl Med. 2018;6:177-177. doi:10.21037/atm.2018. 
04.20.
 74. Frederiksen HR, Haukedal H, Freude K, Muthuraju S. Cell type specific expres-
sion of toll-like receptors in human brains and implications in Alzheimer’s dis-
ease. Biomed Res Int. 2019;2019:1-18. doi:10.1155/2019/7420189.
 75. Thériault P, Elali A, Rivest S. The dynamics of monocytes and microglia in 
Alzheimer’s disease. Alzheimer’s Res Ther. 2015;7:1-10. doi:10.1186/s13195-015 
-0125-2.
 76. Law JA, Jacobsen SE. Patterns in plants and animals. Nat Rev Genet. 
2010;11:204-220. doi:10.1038/nrg2719.Establishing.
 77. Duncan EJ, Gluckman PD, Dearden PK. Epigenetics, plasticity, and evolution: 
how do we link epigenetic change to phenotype? J Exp Zool Part B Mol Dev Evol. 
2014;322:208-220. doi:10.1002/jez.b.22571.
 78. Kochmanski J, Marchlewicz EH, Savidge M, et al. Longitudinal effects of 
developmental bisphenol a and variable diet exposures on epigenetic drift in 
mice. Reprod Toxicol. 2018;68:154-163. doi:10.1016/j.reprotox.2016.07.021.
Longitudinal.
 79. Saenen ND, Plusquin M, Bijnens E, et al. In Utero fine particle air pollution and pla-
cental expression of genes in the brain-derived neurotrophic factor signaling pathway: 
an environage birth cohort study. Environ Health Perspect. 2015;123:834-840.
 80. Yu L, Chibnik LB, Srivastava GP, et al. Association of brain DNA Methylation 
in SORL1, ABCA7, HLA-DRB5, SLC24A4, and BIN1 with pathological 
diagnosis of Alzheimer disease. JAMA Neurol. 2015;72:15-24. doi:10.1001/
jamaneurol.2014.3049.
 81. Coppieters N, Dieriks BV, Lill C, Faull RLM, Curtis MA, Dragunow M. 
Global changes in DNA methylation and hydroxymethylation in Alzheimer’s 
disease human brain. Neurobiol Aging. 2014;35:1334-1344. doi:10.1016/j.
neurobiolaging.2013.11.031.
 82. Pogribny IP, Beland FA. DNA hypomethylation in the origin and pathogenesis 
of human diseases. Cell Mol Life Sci. 2009;66:2249-2261. doi:10.1007/
s00018-009-0015-5.
 83. Konki M, Malonzo M, Karlsson IK, et al. Peripheral blood DNA methylation 
differences in twin pairs discordant for Alzheimer’s disease. Clin Epigenetics. 
2019;11:1-12. doi:10.1186/s13148-019-0729-7.
 84. Perera BPU, Svoboda LK, Dolinoy DC. Genomic tools for environmental epi-
genetics and implications for public health. Curr Opin Toxicol. 2019;18:27-33. 
doi:10.1016/j.cotox.2019.02.008.
 85. Velayudhan L, Proitsi P, Westman E, et al. Entorhinal cortex thickness predicts 
cognitive decline in Alzheimer’s disease. J Alzheimer’s Dis. 2013;33:755-766. 
doi:10.3233/JAD-2012-121408.
 86. Diao M, Holloway T, Choi S, et al. Methods, availability, and applications of 
PM2.5 exposure estimates derived from ground measurements, satellite, and 
atmospheric models. J Air Waste Manage Assoc. 2019;69:1391-1414. doi:10.1080/1
0962247.2019.1668498.
 87. Lindaas J, Farmer DK, Pollack IB, et al. Changes in ozone and precursors during 
two aged wildfire smoke events in the Colorado Front Range in summer 2015. 
Atmos Chem Phys. 2017;17:10691-10707. doi:10.5194/acp-17-10691-2017.
 88. Wojsiat J, Prandelli C, Laskowska-Kaszub K, Martín-Requero A, Wojda U. Oxi-
dative stress and aberrant cell cycle in Alzheimer’s disease lymphocytes: diagnostic 
prospects. J Alzheimer’s Dis. 2015;46:329-350. doi:10.3233/JAD-141977.
 89. Esteras N, Alquézar C, de la Encarnación A, Martín-Requero Á. Lymphocytes 
in Alzheimer’s disease pathology: altered signaling pathways. Curr Alzheimer 
Res. 2016;13:439-449. doi:10.2174/1567205013666151116124912.
